BrdU anticorps
-
- Antigène Voir toutes BrdU Anticorps
- BrdU (Bromodeoxyuridine (BrdU))
- Reactivité
- Humain, Souris, Rat
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp BrdU est non-conjugé
-
Application
- Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA
- Purification
- Protein A+G purification
- Pureté
- ≥95 % as determined by SDS-PAGE
- Immunogène
- compound
- Clone
- 9E8
- Isotype
- IgG2a
- Top Product
- Discover our top product BrdU Anticorps primaire
-
-
- Indications d'application
- IHC: 1:200-1:1000, IF: 1:50-1:500
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Date de péremption
- 12 months
-
- Antigène
- BrdU (Bromodeoxyuridine (BrdU))
- Autre désignation
- BrdU (BrdU Produits)
- Classe de substances
- Chemical
- Sujet
- Synonyms:5-bromo-2-deoxyuridine, BrDu, BrdUrd, Bromodeoxyuridine, BUdR Background:Bromodeoxyuridine(5-bromo-2'-deoxyuridine, BrdU, BUdR, BrdUrd) is a synthetic nucleoside that is an analog of thymidine. It can be incorporated into the newly synthesized DNA of replicating cells(during the S phase of the cell cycle), substituting for thymidine during DNA replication. As such, BrdU is used for birth dating and monitoring cell proliferation. BrdU is a toxic and mutagenic substance. It triggers cell death, the formation of teratomas, alters DNA stability, lengthens the cell cycle, and has mitogenic, transcriptional and translational effects on cells that incorporate it. This antibody does not cross react with Thymidine.
-